ClinicalTrials.gg
RecruitingNCT06570603Updated Jul 10, 2025

Targeting Components of Distress Tolerance

An interventional study of Self-Efficacy and Willingness in Distress, Emotional, sponsored by University of Arkansas, Fayetteville. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-10.

Sponsored by University of Arkansas, Fayetteville · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn which aspects of distress intolerance (i.e., difficulties withstanding upsetting emotional states) are the most important for improving effective emotion regulation and associated mental health symptoms.

The main questions it aims to answer are:

How are willingness to feel upset and self-efficacy for withstanding distress associated with different emotion regulation strategies used in daily life?

Does targeting willingness to feel upset and/or self-efficacy for withstanding distress help people use more effective emotion regulation strategies in daily life when they feel upset?

Are improvements in emotion regulation strategies in daily life associated with fewer symptoms of mental health problems over time?

Participants will:

Answer questions about their moods, willingness to feel upset, self-efficacy for withstanding distress and emotion regulation strategies for three weeks using a cell phone app

Undergo a willingness, self-efficacy, combined or psychoeducational control intervention in the lab

Be prompted to use the intervention skill via the cell phone app during the second week, after the intervention

Complete weekly reports of mental health symptoms

02

Conditions studied

  • Distress, Emotional
03

In context

Lead sponsor

University of Arkansas, Fayetteville is the lead sponsor of 29 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fluent in English
  • Uses Android or iPhone smartphone
  • Depression Anxiety and Stress Scale (DASS-21) scores of 42 and higher
  • Distress Intolerance Index (DII) scores of 3 or higher

Exclusion criteria

Exclusion Criteria:

  • Work or School that does not allow consistent access to phone (or is unsafe)
  • No internet access for completing follow-up surveys
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
240 participants (estimated)

Study arms

  • Placebo comparator
    Psychoeducational Control

    Participants will receive psychoeducation only

    Behavioral: Psychoeducation

  • Experimental
    Self-Efficacy (Only)

    Single session intervention focusing on increasing self-efficacy to manage distress. Will include brief psychoeducation about emotion, then a focus on agency and self-criticism, using stressors the participant provided from the previous week, with an aim to teach self-compassion skills that will improve self-efficacy.

    Behavioral: Self-Efficacy · Behavioral: Psychoeducation

  • Experimental
    Willingness (Only)

    Single session intervention focused on increasing willingness to allow distress. Will include brief psychoeducation about emotion, then a discussion of values and how allowing and experiencing emotions nourishes values, experiencing discomfort enhances growth. Will use stressors from the prior week as examples.

    Behavioral: Willingness · Behavioral: Psychoeducation

  • Experimental
    Combined Willingness and Self-Efficacy

    Single session intervention focused on increasing both willingness and self-efficacy. Will include brief psychoeducation about emotion, then a combination of using values and self-compassion to increase both allowing and self-efficacy.

    Behavioral: Self-Efficacy · Behavioral: Willingness · Behavioral: Psychoeducation

Interventions

  • BehavioralSelf-Efficacy

    Brief skills based psychotherapy session to increase perceived self-efficacy for withstanding distress, giving participants increased beliefs that they \*can\* do it.

  • BehavioralWillingness

    Brief skills based psychotherapy session to increase perceived willingness to engage with distress for withstanding distress, giving participants increased motivation to try.

  • BehavioralPsychoeducation

    Psychoeducation about the components and functions of emotion.

06

What researchers measure

Primary outcomes

  1. Engagement behaviors

    Emotion regulation strategies reflective of engagement; these are new items developed for this study and are not from an established scale. All items will be rated from 0 (not at all) to 6 (extremely). There will be 7 items assessing labeling ("I'm using emotion words to describe how I feel right now"), processing ("I'm reflecting on or writing about my feelings"), sharing ("I'm sharing how I feel with another person"), physical feeling ("I'm intentionally feeling my feelings in my body"), curiously considering ("I'm curiously considering how my feelings came about"), defusion ("I'm observing my feelings without getting 'stuck' in them"), and importance ("I'm trying to think about how this current situation maps on to what matters.")

    Time frame: Assessed 5x/day via ecological momentary assessment

  2. Disengagement behaviors

    Emotion regulation strategies reflective of disengagement, some of which were modified from a momentary experiential avoidance measure (Hershenberg et al., 2017). All items will be rated from 0 (not at all) to 6 (extremely).Items will assess distraction ("Trying to distract myself from my feelings'), thought suppression ("Trying to push unwanted thoughts out of my mind."), discounting ("I'm telling myself I shouldn't be feeling the way I'm feeling"), expressive suppression ("I'm trying to control my feelings by not expressing them"), procrastination ("I'm intentionally putting of an unpleasant task until later"), denial ("I'm trying to 'turn off' the feelings that I don't want to feel"), and reduce importance ("Trying to think about the current situation as unimportant to me.")

    Time frame: Assessed 5x/day via ecological momentary assessment

  3. GAD-7

    Symptoms of anxiety

    Time frame: Baseline, weekly for three weeks and then after one month followup

  4. PHQ-9

    symptoms of depression

    Time frame: Baseline, weekly for three weeks and then after one month followup

  5. AUDIT

    Alcohol misuse

    Time frame: Baseline, weekly for three weeks and then after one month followup

  6. Binge Eating Disorder Scale

    binge eating symptoms

    Time frame: Baseline, weekly for three weeks and then after one month followup

  7. DSM Cross-Cutting Symptom Measure

    symptoms of psychopathology

    Time frame: Baseline, weekly for three weeks and then after one month followup

Secondary outcomes

  1. Satisfaction with Life Scale (SWLS)

    life satisfaction

    Time frame: Baseline, weekly for three weeks and then after one month followup

  2. Self-Compassion Scale - Short

    self-criticism and self-compassion

    Time frame: Baseline, weekly for three weeks and then after one month followup

  3. State Loss of Interest and Pleasure Scale

    anhedonia

    Time frame: Baseline, weekly for three weeks and then after one month followup

  4. Rumination and Reflection Questionnaire

    rumination and self-reflective tendencies

    Time frame: Baseline, weekly for three weeks and then after one month followup

07

Study locations

1 of 1 sites recruiting
  • University of Arkansas - Fayetteville
    Fayetteville, Arkansas 72701, United States
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2024 (actual). Primary completion is estimated for Dec 2026, 26 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2024
First posted
Aug 26, 2024
StartActual
Oct 3, 2024
Primary completionEst.
Dec 2026
CompletionEst.
Apr 2027
Last update
Jul 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06570603
Lead sponsor
University of Arkansas, Fayetteville
Responsible party
Jennifer C Veilleux (Associate Professor, University of Arkansas, Fayetteville) — Principal investigator
First posted
Aug 26, 2024
Start date
Oct 3, 2024
Primary completion
Dec 2026 (estimated)
Completion
Apr 2027 (estimated)
Last update
Jul 10, 2025

Study contacts

Jennifer C Veilleux, PhD
Contact
jcveille@uark.edu
479-575-5329

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion